Your browser doesn't support javascript.
loading
Outcomes of Patients Undergoing Combined Heart-Kidney Transplantation With or Without Prior Ventricular Assist Device.
Currie, Maria; Leipzig, Matthew; Kaghazchi, Aydin; Zhu, Yuanjia; Shudo, Yasuhiro; Woo, Y Joseph.
Afiliação
  • Currie M; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California. Electronic address: mecurrie@stanford.edu.
  • Leipzig M; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
  • Kaghazchi A; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
  • Zhu Y; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
  • Shudo Y; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
  • Woo YJ; Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Transplant Proc ; 55(7): 1674-1680, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37393169
ABSTRACT

BACKGROUND:

Both combined heart-kidney transplantation and ventricular assist devices (VADs) pose significant challenges, including sensitization, immunosuppressive treatment, and infrastructure demands. Despite these challenges, we hypothesized that the recipients of combined heart-kidney transplants with and without VADs would have equivalent survival. We aimed to compare the survival of heart-kidney transplant recipients with and without prior VAD placement.

METHODS:

We retrospectively analyzed all patients enrolled in the United Network for Organ Sharing database who underwent heart-kidney transplants. We created a matched cohort of patients undergoing heart-kidney transplantation with or without prior VAD using 11 nearest propensity-score matching with preoperative variables.

RESULTS:

In the propensity-matched cohort, 399 patients underwent heart-kidney transplantation with prior VAD, and 399 underwent heart-kidney transplantation without prior VAD. The estimated survival of heart--kidney recipients with prior VAD was 84.8% at one year, 81.2% at 3 years, and 75.3% at 5 years. The estimated survival of heart-kidney recipients without prior VAD was 86.8.7% at one year, 84.0% at 3 years, and 78.8% at 5 years. There was no statistically significant difference in the survival of heart-kidney transplant recipients with or without prior VAD at one year (P = .42; Figure 2), 3 years (P = .34), or 5 years (P = .30).

CONCLUSION:

Despite the increased challenge of heart-kidney transplantation in recipients with prior VAD, we demonstrated that these patients have similar survival to those who underwent heart-kidney transplantation without previous VAD placement.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coração Auxiliar / Transplante de Coração / Transplante de Rim / Insuficiência Cardíaca Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coração Auxiliar / Transplante de Coração / Transplante de Rim / Insuficiência Cardíaca Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article